A 20-year-old male presented with thoracic spinal cord compression due to epidural Ewing sarcoma, requiring urgent surgical decompression and multidisciplinary treatment, as reported in two medical journals.
Ewing Sarcoma Affects Spine in Young Adult
Ewing sarcoma, a rare malignant tumor typically affecting children and adolescents, rarely involves the spine. A 20-year-old male developed lower limb flaccid paraparesis and urinary dysfunction, leading to the diagnosis of thoracic epidural Ewing sarcoma. MRI revealed a hyperintense lesion from TH5 to TH7 vertebrae, compressing the spinal cord and extending into the epidural space (Nih).
The case highlights the aggressive nature of spinal Ewing sarcoma, which accounts for 3.5–14.9% of all Ewing sarcoma cases. Unlike typical presentations in long bones, this patient’s tumor localized to the thoracic spine, necessitating urgent surgical intervention. The diagnosis was confirmed via histopathological analysis of the resected specimen (Cureus).
Ewing sarcoma is a primary malignant tumor that mainly affects people in their second decade of life, primarily targeting those between 10 and 25 years old, with the average age of onset approximately 20 years (Nih). First identified in 1921 by James Ewing, it primarily affects individuals in their second decade of life, meaning it is most prevalent among young people (Nih).
Imaging and Surgical Management
MRI findings in the Cureus case showed a T1-hyperintense lesion with gadolinium enhancement, extending into the left paravertebral soft tissues. The patient underwent a laminectomy of TH5, TH6, and TH7 vertebrae, preserving the articulating joint complexes to achieve medullary decompression and remove the tumor (Cureus). Histopathological examination revealed a malignant tumor consisting of undifferentiated round cells (Cureus).
Imaging details from the Cureus article include a T2 sequence isodense to hyperdense formation at TH5–TH7 vertebral projections, filling the posterolateral epidural space and compressing the spinal cord with local edema. Soft tissue destruction of the TH7 vertebra was also observed (Cureus). The clinical presentation and radiological findings are nonspecific, necessitating diagnostic biopsy for confirmation (Cureus).
The Nih article emphasizes that spinal involvement is uncommon, with most cases presenting as sacral tumors. This thoracic localization underscores the need for early diagnosis, as delayed treatment risks irreversible neurological damage. Surgical decompression, combined with chemotherapy and radiation, is the standard approach, though outcomes vary based on tumor stage and resectability (Nih).
Risks and Outcomes of Surgical Treatment
Spinal Ewing sarcoma poses unique challenges due to its proximity to the spinal cord. The Cureus case notes that surgical resection carries risks of tumor dissemination, necessitating careful preoperative planning. Postoperative chemotherapy and radiotherapy were initiated, aligning with guidelines for high-grade sarcomas. However, long-term prognosis remains guarded, particularly in cases with delayed diagnosis (Cureus).
The Nih report references studies showing that radical surgery improves survival, but the decision to proceed depends on tumor location and neurological status. In this case, the patient’s progressive neurological deficits necessitated immediate decompression, highlighting the importance of multidisciplinary collaboration in managing rare spinal malignancies (Nih). Six months later, the patient developed headaches and exophthalmos; a brain MRI revealed an orbital lesion, prompting an oncology team review for additional chemotherapy (Cureus).
Clinical Implications and Future Directions
This case underscores the need for heightened awareness of Ewing sarcoma’s atypical presentations. Clinicians should consider spinal involvement in young patients with unexplained neurological deficits, particularly when imaging reveals unusual lesions. Further research is needed to refine treatment protocols for spinal Ewing sarcoma, balancing aggressive intervention with preserving neurological function (Nih).
The Cureus article also notes that spinal MRI remains the gold standard for evaluating such cases, aiding in both diagnosis and surgical planning. As Ewing sarcoma’s genetic underpinnings become clearer, targeted therapies may offer new hope for patients with rare or advanced presentations (Cureus). The study was published on October 4, 2026, by Bouchkara K, BAAYOUD K, KADIRI ALAOUI N, et al., with a Scholary Impact Quotient rating based on post-publication peer review (Cureus).
For patients with spinal Ewing sarcoma, multidisciplinary care involving oncologists, neurosurgeons, and radiologists is critical. The prognosis remains guarded in metastatic cases, but early intervention can improve outcomes. Readers should consult qualified professionals for personalized medical advice, as this article does not provide treatment recommendations (Nih).